BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 167564)

  • 1. Antimuscarinic actions of neuroleptic drugs.
    Miller R; Hiley R
    Adv Neurol; 1975; 9():141-54. PubMed ID: 167564
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
    Glowinski J
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
    [No Abstract]   [Full Text] [Related]  

  • 3. Actions of dopaminergic agonists on cyclic AMP production in rat brain homogenates.
    Iversen LL; Horn AS; Miller RJ
    Adv Neurol; 1975; 9():197-212. PubMed ID: 167565
    [No Abstract]   [Full Text] [Related]  

  • 4. New developments in the study of the mechanism of action of neuroleptics and amphetamine.
    Glowinski J
    J Psychiatr Res; 1974; 11():81-5. PubMed ID: 4156794
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta.
    Ferris RM; Tang FL; Maxwell RA
    J Pharmacol Exp Ther; 1972 Jun; 181(3):407-16. PubMed ID: 5033010
    [No Abstract]   [Full Text] [Related]  

  • 6. Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex.
    Heikkila RE; Orlansky H; Mytilineou C; Cohen G
    J Pharmacol Exp Ther; 1975 Jul; 194(1):47-56. PubMed ID: 1151755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The antipsychotic action of neuroleptics and basal ganglia function].
    Arushanian EB
    Farmakol Toksikol; 1973; 26(4):481-9. PubMed ID: 4151298
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH; VAN Woert MH
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacotherapy of schizophrenia.
    Ban TA
    Curr Psychiatr Ther; 1976; 16():163-75. PubMed ID: 991627
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential catecholamine uptake inhibition as a possible mode of action of D-amphetamine induced locomotor activity.
    Feigenbaum J; Yanai J; Klawans H; Moon B
    Res Commun Chem Pathol Pharmacol; 1983 Feb; 39(2):349-52. PubMed ID: 6844751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinsonism induced by dopaminergic antagonists.
    Hornykiewicz O
    Adv Neurol; 1975; 9():155-64. PubMed ID: 1096571
    [No Abstract]   [Full Text] [Related]  

  • 12. Central catecholamine neurons, behavior and neuroleptic drugs: an analysis to understand the involvement of catecholamines in schizophrenia.
    Fuxe K; Nyström M; Tovi M; Smith R; Ogren SO
    J Psychiatr Res; 1974; 11():151-61. PubMed ID: 4156786
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopaminergic supersensitivity in the striatum.
    Ungerstedt U; Ljungberg T; Hoffer B; Siggins G
    Adv Neurol; 1975; 9():57-65. PubMed ID: 167568
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction.
    Randrup A
    Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential effects of neuroleptic drugs on amphetamine-induced stimulation of locomotor activity in 11-day-old and adult rats.
    Miller R; Sahakian B
    Brain Res; 1974 Dec; 81(2):387-92. PubMed ID: 4154799
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings:Pre- and postsynaptic actions of neuroleptic drugs.
    Iversen LL; Miller RJ; Rogawski M
    Br J Pharmacol; 1975 Oct; 55(2):297P-298P. PubMed ID: 1201424
    [No Abstract]   [Full Text] [Related]  

  • 17. Structure activity relationships for agonist and antagonist drugs at pre- and postsynaptic receptor sites in rat brain.
    Iversen LL; Horn AS; Miller RJ
    Psychopharmacol Bull; 1975 Oct; 11(4):14. PubMed ID: 172932
    [No Abstract]   [Full Text] [Related]  

  • 18. A dopaminergic-cholinergic mechanism in production of psychotic symptoms.
    Friedhoff AJ; Alpert M
    Biol Psychiatry; 1973 Apr; 6(2):165-9. PubMed ID: 4709131
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine turnover in the corpus striatum and the lumbic system after treatment with neuroleptic and anti-acetylcholine drugs.
    Andén NE
    J Pharm Pharmacol; 1972 Nov; 24(11):905-6. PubMed ID: 4405656
    [No Abstract]   [Full Text] [Related]  

  • 20. Action of opiates, antipsychotics, amphetamine and apomorphine on dopamine receptors in rat striatum: in vivo changes of 3',5'-cyclic AMP content and acetylcholine turnover rate.
    Carenzi A; Cheney DL; Costa E; Guidotti A; Racagni G
    Neuropharmacology; 1975 Dec; 14(12):927-39. PubMed ID: 3748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.